In the evolving lexicon of human capital management, organizations frequently overlook a critical systemic vulnerability: the midcareer crisis. While corporate... Read more
Category: Uncategorized
The AI productivity paradox: When managers become the new organizational bottleneck
The approval logjam and the illusion of abundance Artificial intelligence is driving an unprecedented acceleration in the execution of daily... Read more
Eye Injuries – Early Recognition, Proper First Aid, Reducing The Rick Of Vision Loss
Eye injuries are common in occupational settings, sports activities, traffic accidents, and daily life. Although some injuries may initially appear... Read more
Abbott captures European CE mark for pioneering dual glucose and ketone continuous sensor
Medical technology conglomerate Abbott announced on Wednesday that it has secured Europe’s CE mark for its novel Libre Duo device,... Read more
Olympus executes $270 million acquisition of BioProtect to scale prostate cancer care pipeline
Medtech conglomerate Olympus Corporation has finalized a definitive agreement to acquire implantable technology innovator BioProtect for a total consideration of... Read more
US FDA approves AbbVie’s targeted therapeutic formulation for rare blood cancer
The United States Food and Drug Administration (FDA) has granted formal regulatory approval to AbbVie’s novel therapeutic agent engineered for... Read more
CordenPharma acquires AmbioPharm, securing new peptide manufacturing hubs in the US and China
Amid an intensive capital mobilization program driving next-generation weight-loss manufacturing expansions, global contract development and manufacturing organization (CDMO) CordenPharma has... Read more
Viridian taps WuXi Biologics in commercial supply pact for thyroid eye disease drug ahead of US FDA verdict
U.S. clinical-stage biotech Viridian Therapeutics is shoring up its commercial supply infrastructure as its thyroid eye disease (TED) candidate, veligrotug,... Read more
J&J terminates 56 employees in New Jersey amid strategic separation of its orthopedics unit
Healthcare conglomerate Johnson & Johnson (J&J) is dismissing 56 employees at its global corporate headquarters in New Brunswick, New Jersey.... Read more









